Methods for reactivating genes on the inactive X chromosome
AssigneeThe General Hospital Corporation
InventorsJeannie T. Lee, Anand Minajigi, Lieselot Carrette
Life of this patent
Estimating the term…
Abstract
Methods for reactivating genes on the inactive X chromosome that include administering one or both of a DNA methyltransferase (DNMT) Inhibitor and/or a topoisomerase inhibitor, e.g., etoposide and/or 5′-azacytidine (aza), optionally in combination with an inhibitor of XIST RNA and/or an Xist-interacting protein, e.g., a chromatin-modifying protein, e.g., a small molecule or an inhibitory nucleic acid (such as a small inhibitory RNA (siRNAs) or antisense oligonucleotide (ASO)) that targets XIST RNA and/or a gene encoding an Xist-interacting protein, e.g., a chromatin-modifying protein.
Claims15
A composition comprising a DNMT Inhibitor and an inhibitory nucleic acid targeting XIST RNA.
Dependencies are inferred from the claim text.